De Simone, P.; Bronzoni, J.; Martinelli, C.; Ducci, J.; Campani, D.; Gitto, S.; Marchetti, P.; Biancofiore, G. Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation. J. Clin. Med.2024, 13, 1087.
De Simone, P.; Bronzoni, J.; Martinelli, C.; Ducci, J.; Campani, D.; Gitto, S.; Marchetti, P.; Biancofiore, G. Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation. J. Clin. Med. 2024, 13, 1087.
De Simone, P.; Bronzoni, J.; Martinelli, C.; Ducci, J.; Campani, D.; Gitto, S.; Marchetti, P.; Biancofiore, G. Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation. J. Clin. Med.2024, 13, 1087.
De Simone, P.; Bronzoni, J.; Martinelli, C.; Ducci, J.; Campani, D.; Gitto, S.; Marchetti, P.; Biancofiore, G. Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation. J. Clin. Med. 2024, 13, 1087.
Abstract
We conducted a hybrid-design study on a historical cohort of 359 adult recipients of a liver graft who received transplants between 1996 and 2002. The study aimed to identify predictors of survival and investigate the prevalence of co-morbidities among long-term survivors. The actuarial (95% CI) patient survival of the overall study cohort was 96% (94.6%-98.3%), 69% (64.2%-73.6%), 55% (49.8%-59.9%), 42.8% (37.6%-47.8%), and 34% (29.2%-38.9%) at 1, 5, 10, 15, and 20 years, respectively. The actuarial (95% CI) graft survival was 93.8% (91.6%-97.2%), 67.6% (62.2%-71.5%), 54.3% (49.6%-59.3%), 42.1% (37.3%-47.4%), and 33.8% (29.0%-38.4%) at 1, 5, 10, 15, and 20 years, respectively. The leading cause of death was hepatitis C virus recurrence (24.6%), followed by extrahepatic malignancies (16.9%), infection (14.4%), and hepatocellular carcinoma recurrence (14.4%). The Cox proportional hazards analysis revealed that several independent factors were associated with the survival probability. These factors include younger donor and recipient ages (p=0.001 and 0.004, respectively), female recipient sex (p<0.001), absence of HCV (p<0.01), absence of HCC (p=0.001), and absence of diabetes mellitus at one year (p<0.01). At the latest follow-up, the leading comorbidities in the long-term survivors were hypertension (53.6%), obesity (18.7%), diabetes mellitus (17.1%), hyperlipidemia (14.7%), chronic kidney dysfunction (14.7%), and extrahepatic malignancies (13.8%), with 73.9% of patients having more than one complication. The Kaplan-Meier probability (95% CI) of complication-free survival was 65.4% (60.2%-70.3%), 38.4% (33.4%-43.7%), 17.8% (14.1%-22.2%), 7.2% (4.8%-10.5%), and 1.94% (0.85%-4.15%) at 1, 5, 10, 15, and 20 years, respectively. Aging with a liver graft is associated with an increased risk of complications and requires ongoing care to reduce the long-term attrition rate resulting from chronic immunosuppression.
Keywords
liver transplantation; long term survival; aging; immunosuppression
Subject
Medicine and Pharmacology, Transplantation
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
,
,
,
,
,
,
